Application 018780
- Type
- BLA
- Sponsor
- LILLY
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | HUMULIN R | INSULIN RECOMBINANT HUMAN | INJECTABLE;INJECTION | 100 UNITS/ML | No | No |
| 002 | HUMULIN R KWIKPEN | INSULIN HUMAN | SOLUTION;SUBCUTANEOUS | 1500 UNITS/3ML (500 UNITS/ML) | No | No |
| 004 | HUMULIN R | INSULIN HUMAN | SOLUTION;SUBCUTANEOUS | 10000 UNITS/20ML (500 UNITS/ML) | No | No |
| 005 | HUMULIN R PEN | INSULIN RECOMBINANT HUMAN | INJECTABLE;INJECTION | 100 UNITS/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0002-8215 | Humulin | Insulin human | Eli Lilly and Company | BLA | Current |
| 0002-8215 | Humulin | Insulin human | Eli Lilly and Company | NDA | Current |
| 0002-8215 | Humulin | Insulin human | Eli Lilly and Company | NDA | Current |
| 0002-8215 | Humulin | Insulin human | Eli Lilly and Company | BLA | Current |
| 0002-8215 | Humulin | Insulin human | Eli Lilly and Company | BLA | Current |
| 0002-8501 | Humulin | Insulin human | Eli Lilly and Company | BLA | Current |
| 0002-8501 | Humulin | Insulin human | Eli Lilly and Company | BLA | Current |
| 0002-8501 | Humulin | Insulin human | Eli Lilly and Company | BLA | Current |
| 0002-8501 | Humulin | Insulin human | Eli Lilly and Company | NDA | Current |
| 0002-8501 | Humulin | Insulin human | Eli Lilly and Company | NDA | Current |
| 0002-8501 | Humulin | Insulin human | Eli Lilly and Company | NDA | Current |
| 0002-8824 | Humulin | Insulin human | Eli Lilly and Company | BLA | Current |
| 0002-8824 | Humulin | Insulin human | Eli Lilly and Company | BLA | Current |
| 0002-8824 | Humulin | Insulin human | Eli Lilly and Company | BLA | Current |
| 0002-8824 | Humulin | Insulin human | Eli Lilly and Company | NDA | Current |
| 0002-8824 | Humulin | Insulin human | Eli Lilly and Company | NDA | Current |
| 0002-8824 | Humulin | Insulin human | Eli Lilly and Company | NDA | Current |
| 50090-0353 | Humulin | Insulin human | A-S Medication Solutions | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 71482 | SUPPL | 2022-06-30 |
| 71461 | SUPPL | 2022-06-28 |
| 64284 | SUPPL | 2020-08-17 |
| 66369 | APPL | 2020-03-23 |
| 60934 | SUPPL | 2020-03-23 |
| 60933 | SUPPL | 2020-03-23 |
| 60903 | SUPPL | 2020-03-23 |
| 60901 | SUPPL | 2020-03-23 |
| 59838 | SUPPL | 2020-03-23 |
| 59822 | SUPPL | 2020-03-23 |
| 56445 | SUPPL | 2020-03-23 |
| 56370 | SUPPL | 2020-03-23 |
| 54379 | SUPPL | 2020-03-23 |
| 54378 | SUPPL | 2020-03-23 |
| 54375 | SUPPL | 2020-03-23 |
| 54374 | SUPPL | 2020-03-23 |
| 47639 | SUPPL | 2020-03-23 |
| 33601 | SUPPL | 2020-03-23 |
| 33600 | SUPPL | 2020-03-23 |
| 33599 | SUPPL | 2020-03-23 |
| 33598 | SUPPL | 2020-03-23 |
| 33597 | SUPPL | 2020-03-23 |
| 33596 | SUPPL | 2020-03-23 |
| 20158 | SUPPL | 2020-03-23 |
| 16045 | SUPPL | 2020-03-23 |
| 16044 | SUPPL | 2020-03-23 |
| 16043 | SUPPL | 2020-03-23 |
| 16042 | SUPPL | 2020-03-23 |
| 16041 | SUPPL | 2020-03-23 |
| 16040 | SUPPL | 2020-03-23 |
| 16039 | SUPPL | 2020-03-23 |
| 11330 | SUPPL | 2020-03-23 |
| 11329 | SUPPL | 2020-03-23 |
| 11328 | SUPPL | 2020-03-23 |
| 11327 | SUPPL | 2020-03-23 |
| 11326 | SUPPL | 2020-03-23 |
| 11325 | SUPPL | 2020-03-23 |
| 11324 | SUPPL | 2020-03-23 |
| 11323 | SUPPL | 2020-03-23 |
| 1078 | SUPPL | 2020-03-23 |
| 1077 | SUPPL | 2020-03-23 |
| 1076 | SUPPL | 2020-03-23 |
| 1075 | SUPPL | 2020-03-23 |
| 1074 | SUPPL | 2020-03-23 |
| 1073 | SUPPL | 2020-03-23 |
| 1072 | SUPPL | 2020-03-23 |
| 1071 | SUPPL | 2020-03-23 |
| 1070 | SUPPL | 2020-03-23 |
| 1069 | SUPPL | 2020-03-23 |